Cargando…
Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials
OBJECTIVES: To evaluate the efficacy of nafamostat mesilate in the prevention of post–endoscopic retrograde cholangiopancreatography pancreatitis (PEP) by conduct a systematic review and meta-analysis. METHOD: We retrieved for all randomized controlled trials (RCTs) about compare nafamostat mesilate...
Autores principales: | Xie, Yu, Cheng, Ziyao, Deng, Cunliang, Deng, Mingming, Zhang, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578773/ https://www.ncbi.nlm.nih.gov/pubmed/37832051 http://dx.doi.org/10.1097/MD.0000000000035174 |
Ejemplares similares
-
Clinical efficacy of endoscopic retrograde cholangiopancreatography in the treatment of acute biliary pancreatitis: a meta-analysis
por: Tang, Dan, et al.
Publicado: (2022) -
Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate
por: Chang, Jae Hyuck, et al.
Publicado: (2009) -
Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis
por: Shi, Qing-Qing, et al.
Publicado: (2022) -
Safety of endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy: A systematic review and meta-analysis
por: Azab, Mohamed, et al.
Publicado: (2019) -
Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events
por: Mashiana, Harmeet Singh, et al.
Publicado: (2018)